Core Viewpoint - The company has received approval for its LinX continuous glucose monitoring system in Brazil, which will significantly enhance its market presence in Latin America and support international business expansion and revenue growth [1] Group 1: Product Approval - The LinX continuous glucose monitoring system is now approved for use in both adults and children in Brazil [1] Group 2: Market Impact - The approval is expected to strengthen the company's market positioning in Latin America, laying a solid foundation for scaling international operations and increasing revenue [1] Group 3: Future Focus - The company will continue to focus on the global development of diabetes monitoring, treatment, and management, while driving innovation in related technologies and products [1]
微泰医疗-BLinX持续葡萄糖监测系统在巴西获批上市